Urinary Bladder Cancer Risk Factors: A Lebanese Case-Control Study |
Kobeissi, Loulou Hassan
(Mel and Enid Zuckerman College of Public Health, University of Arizona)
Yassine, Ibrahim Adnan (Faculty of Health Sciences, University of Balamand) Jabbour, Michel Elias (Urology Department, St George Hospital University Medical Center) Moussa, Mohamad Ahmad (Urology Division, Bahman Hospital) Dhaini, Hassan Rida (Faculty of Health Sciences, University of Balamand) |
1 | Axtell C, Ward E, McCabe G, et al (1998). Underlying and multiple cause mortality in a cohort of workers exposed to aromatic amines. Am J Ind Med, 34, 506-11 DOI |
2 | Band P, Le N, MacArthur A, et al (2005). Identification of occupational cancer risks in British Columbia: a populationbased case-control study of 1129 cases of bladder cancer. J Occup Environ Med, 47, 854-8 |
3 | Brennan P, Bogillot O, Cordier S, et al (2000). Cigarette smoking and bladder cancer in men: a pooled analysis of 11casecontrol studies. Int J Cancer, 86, 289-94 DOI |
4 | Butcher N, Ilett K, Minchin R (1998). Functional polymorphism of the human arylamine N-acetyltransferase type 1 gene caused by C190T and G560A mutations. Pharmacogenetics, 8, 67-72 DOI |
5 | Clavel J, Mandereau L, Limasset J, et al (1994). Occupational exposure to polycyclic aromatic hydrocarbons and the risk of bladder cancer. Int J Epidemiol, 23, 1145-53 DOI ScienceOn |
6 | Deitz A, Doll M, Hein D (1997). A restriction fragment length polymorphism assay that differentiates human N-acetyltransferase-1 (NAT1). Anal Biochem, 253, 219-24 DOI ScienceOn |
7 | Dhaini H, Levy G (2000). Arylamine N-acetyltransferase 1 (NAT1) genotypes in a Lebanese population. Pharmacogenetics, 10, 79-83 DOI |
8 | Ferlay J, Shin H, Bray F, et al (2010). Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer, 127, 2893-917 DOI ScienceOn |
9 | Gago-Dominguez M, Bell D, Watson M, et al (2003). Permanent hair dyes and bladder cancer: risk modification by cytochrome P4501A2 and N-acetyltransferases 1 and 2. Carcinogenesis, 24, 483-9 DOI ScienceOn |
10 | Hein D, Doll M, Fretland A, et al (2000). Molecular genetics and epidemiology of the NAT1 and NAT2 Acetylation Polymorphism. Cancer Epidemiol Biomarkers Prev, 9, 29-42 |
11 | Hein D, Grant D, Sim E (2000). Update on consensus arylamine N-acetyltransferase gene nomenclature. Pharmacogenetics, 10, 291-2 DOI |
12 | Hoover R, Strasser P (1980). Artificial sweeteners and human bladder cancer: preliminary results. Lancet, 1, 837-40 |
13 | Hughes N, Janezic S, McQueen K, et al (1998). Identification and characterization of variant alleles of human acetyltranferase NAT1 with defective function using p-aminosalicylate as an in-vivo and in-vitro probe. Pharmacogenetics, 8, 55-66 DOI |
14 | Iyer V, E. Harris R, Wynder E (1990). Diesel exhaust exposure and bladder cancer risk. Eur J Epidemiol, 6, 49-54 DOI |
15 | Jankovic S, Radosavljevic V (2007). Risk factors for bladder cancer. Tumori, 93, 4-12 |
16 | Jemal R, Bray F, Center M, et al (2011). Global Cancer Statistics. CA Cancer J Clin, 61, 69-90 DOI |
17 | Kellen E, Zeegers M, Paulussen A, et al (2007). Does occupational exposure to PAHs, diesel and aromatic amines interact with smoking and metabolic genetic polymorphisms to increase the risk on bladder cancer?; The Belgian case control study on bladder cancer risk. Cancer Lett, 245, 51-60 DOI ScienceOn |
18 | Kogevinas M, Mannetje A, Cordier S, et al (2003). Occupation and bladder cancer among men in Western Europe. Cancer Causes Control, 14, 907-14 DOI ScienceOn |
19 | Kogevinas M, Trichopoulos D (2002). Urinary bladder cancer. In: Adami H, Hunter D, Trichopoulos D (eds). Textbook of cancer epidemiology. New York: Oxford University Press, 1, 446-66. |
20 | La Vecchia C, Negri E (1996). Nutrition and bladder cancer. Cancer Causes Control, 7, 95-100 DOI |
21 | MOPH, Lebanese Ministry of Public Health-Epidemiological Surveillance Program (2010). National Cancer Registry 2007 Cancer Data. |
22 | Mostafa M, Sheweita S, O'Connor P (1999). Relationship between Schistosomiasis and Bladder Cancer. Clin Microbiol Rev, 12, 97-111 |
23 | Pashos C, Botteman M, Laskin B, et al (2002). Bladder cancer: epidemiology, diagnosis, and management. Cancer Pract, 10, 311-22 DOI ScienceOn |
24 | Nakkash R, Khalil J, Afifi R (2011). The rise in narghile (shisha, hookah) waterpipe tobacco smoking: a qualitative study of perceptions of smokers and non smokers. Biomed Central Public Hlth, 14, 315 |
25 | Negri E, La Vecchia C (2001). Epidemiology and prevention of bladder cancer. Eur J Cancer Prev, 10, 7-14 DOI ScienceOn |
26 | Olfert S, Felknor S, Delclos G (2006). An updated review of the literature: risk factors for bladder cancer with focus on occupational exposures. South Med J, 99, 1256-63 DOI ScienceOn |
27 | Ploeg M, Aben K, Kiemeney L (2009). The present and future burden of urinary bladder cancer in the world. World J Urol, 27, 289-93 DOI ScienceOn |
28 | Renwick A (1993). A data-derived safety (uncertainty) factor for the intense sweetener, saccharin. Food Addit Contam, 10, 337-50 DOI ScienceOn |
29 | Saade G, Abou Jaoude S, Afifi R, et al (2008). Patterns of tobacco use: results from the 2005 Global Youth Tobacco Survey in Lebanon. East Mediterr Hlth J, 16, 1280-9 |
30 | Samanic C, Kogevinas M, Dosemeci M, et al (2006). Smoking and bladder cancer in Spain: effects of tobacco type, timing, environmental tobacco smoke, and gender. Cancer Epidemiol Biomarkers Prev, 15, 1348-54 DOI ScienceOn |
31 | Schoenberg J, Stemhagen A, Mogielnicki A, et al (1984). Casecontrol study of bladder cancer in New Jersey I. J Natl Cancer Inst, 72, 973-81 |
32 | Shamseddine A, Musallam K (2010). Cancer Epidemiology in Lebanon. Middle East J Cancer, 1, 41-4 |
33 | Wilhelm-Benartzi C, Christensen B, Koestler D, et al (2011). Association of secondhand smoke exposures with DNA methylation in bladder carcinomas. Cancer Causes Control, 22, 1205-13 DOI |
34 | Shamseddine A, Sibai A, Gehchan N, et al (2004). Cancer incidence in postwar Lebanon: findings from the first national population-based registry, 1998. Ann Epidemiol, 14, 663-8 DOI ScienceOn |
35 | Vineis P, Marinelli D, Autrup H, et al (2001). Current smoking, occupation, N-acetyltransferase-2 and bladder cancer: a pooled analysis of genotype-based studies. Cancer Epidemiol Biomarkers Prev, 10, 1249-52 |
36 | Wakai K, Hirose K, Takezaki T, et al (2004). Foods and beverages in relation to urothelial cancer: case-control study in Japan. Int J Urol, 11, 11-9 DOI ScienceOn |
37 | World Health Organization. Combating the tobacco epidemic. Geneva: WHO, 1999. |
38 | Yamaguchi N, Tazaki H, Okubo T, et al (1982). Periodic urine cytology surveillance of bladder tumor incidence in dyestuff workers. Am J Ind Med, 3, 139-48 DOI ScienceOn |
39 | Yassine IA, Kobeissi L, Jabbour ME, et al (2012). N-Acetyltransferase 1 (NAT1) Genotype: a risk factor for urinary bladder cancer in a Lebanese population. J Oncol, 2012, 512976 |
40 | Zeegers M, Kellen E, Buntinx F, et al (2004). The association between smoking, beverage consumption, diet and bladder cancer: a systematic literature review. World J Urol, 21, 392-401 DOI ScienceOn |
41 | Zeegers M, Swaen G, Kant I, et al (2001). Occupational risk factors for male bladder cancer: results from a population based case cohort study in the Netherlands. Occup Environ Med, 58, 590-6 DOI |
42 | Zheng Y, Amr S, Saleh D, et al (2012). Urinary Bladder Cancer Risk Factors in Egypt: A Multicenter Case-Control Study. Cancer Epidemiol Biomarkers Prev, 21, 537-46 DOI |